Clinical Trial Update: To Evaluate the Efficacy and Safety of HL151 Versus Placebo in Perennial Allergic Rhinitis Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating HL151 vs placebo in perennial allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perennial Allergic Rhinitis

Drugs mentioned

• HL151

Snippet

Sponsor: Hanlim Pharm. Co., Ltd. | Conditions: Perennial Allergic Rhinitis | Phase 3 | Status: COMPLETED